Literature DB >> 7626791

FGF-2 mRNA and its antisense message are expressed in a developmentally specific manner in the chick limb bud and mesonephros.

M P Savage1, J F Fallon.   

Abstract

FGF-2 protein is present in the ectoderm and mesoderm of the developing chick limb bud. Its importance has been shown by the ability of ectopically applied FGF-2 to replace the apical ectodermal ridge, allowing complete outgrowth and subsequent pattern formation of the limb bud. The first goal of this study was to determine whether FGF-2 mRNA was present in the same ectodermal and mesodermal regions of the chick embryo as FGF-2 protein. FGF-2 also has an antisense message that is convergently transcribed from the opposite DNA strand (Kimelman and Kirschner [1989] Cell 59:687-696; Volk et al. [1989] EMBO J. 8:2983-2988). The second goal was to demonstrate the expression and distribution of the antisense message. Using RNAse protection assays we detected a full length protected fragment that corresponds to chick embryo FGF-2 mRNA, and a partially protected fragment that corresponds to the antisense message. We used in situ hybridization to show that FGF-2 mRNA was present in the ectoderm and subjacent mesoderm of the chick wing bud. FGF-2 mRNA was also present in body ectoderm and undifferentiated mesoderm throughout the embryo, and in muscle cells, dorsal neural tube, and mesonephros. In situ hybridization also revealed evidence for the presence of the natural antisense message in the embryo in most, but not all, of the same regions as the FGF-2 mRNA. FGF-2 mRNA and its antisense message colocalized in undifferentiated limb mesoderm; however, antisense message was not detected in differentiated muscle or cartilage. It is important to note that FGF-2 mRNA was always present in the mesonephros but that the antisense message was never observed in the mesonephros, thereby providing an internal control for non-specific signal. Although little is known about its function, Kimelman and Kirschner ([1989] Cell 59: 687-696) proposed that the antisense message may increase turnover of FGF-2 mRNA. When we compared the in situ hybridization data of both mRNAs with levels of FGF-2 protein (Savage et al. [1994] Dev. Dyn. 198:159-170), interesting tissue specific patterns emerged that support this hypothesis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7626791     DOI: 10.1002/aja.1002020404

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  11 in total

1.  Up-regulation of the chondrogenic Sox9 gene by fibroblast growth factors is mediated by the mitogen-activated protein kinase pathway.

Authors:  S Murakami; M Kan; W L McKeehan; B de Crombrugghe
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

2.  In vivo inhibition of programmed cell death by local administration of FGF-2 and FGF-4 in the interdigital areas of the embryonic chick leg bud.

Authors:  D Macias; Y Gañan; M A Ros; J M Hurle
Journal:  Anat Embryol (Berl)       Date:  1996-06

3.  The KLHL1-antisense transcript ( KLHL1AS) is evolutionarily conserved.

Authors:  Kellie A Benzow; Michael D Koob
Journal:  Mamm Genome       Date:  2002-03       Impact factor: 2.957

4.  Characterization and tissue-specific expression of the rat basic fibroblast growth factor antisense mRNA and protein.

Authors:  R Knee; A W Li; P R Murphy
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

Review 5.  FGF signaling in the developing endochondral skeleton.

Authors:  David M Ornitz
Journal:  Cytokine Growth Factor Rev       Date:  2005-04-01       Impact factor: 7.638

6.  Fibroblast growth factor 18 gives growth and directional cues to airway cartilage.

Authors:  Ravindhra G Elluru; Felisa Thompson; Alisa Reece
Journal:  Laryngoscope       Date:  2009-06       Impact factor: 3.325

7.  PCNA in situ hybridization: a novel and reliable tool for detection of dynamic changes in proliferative activity.

Authors:  Thomas Köhler; Felicitas Pröls; Beate Brand-Saberi
Journal:  Histochem Cell Biol       Date:  2004-12-23       Impact factor: 2.531

8.  Fibroblast growth factor-2 primes human mesenchymal stem cells for enhanced chondrogenesis.

Authors:  Andrew M Handorf; Wan-Ju Li
Journal:  PLoS One       Date:  2011-07-27       Impact factor: 3.240

9.  FGF9 can induce endochondral ossification in cranial mesenchyme.

Authors:  Venkatesh Govindarajan; Paul A Overbeek
Journal:  BMC Dev Biol       Date:  2006-02-20       Impact factor: 1.978

10.  FGFR1 inhibits skeletal muscle atrophy associated with hindlimb suspension.

Authors:  John Eash; Aaron Olsen; Gert Breur; Dave Gerrard; Kevin Hannon
Journal:  BMC Musculoskelet Disord       Date:  2007-04-10       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.